Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

Related Articles by Review for PubMed (Select 23317952)

1.

Anti-tuberculosis treatment outcomes in HIV-infected adults exposed to isoniazid preventive therapy in Botswana.

Sibanda T, Tedla Z, Nyirenda S, Agizew T, Marape M, Miranda AG, Reuter H, Johnson JL, Samandari T.

Int J Tuberc Lung Dis. 2013 Feb;17(2):178-85. doi: 10.5588/ijtld.12.0314.

PMID:
23317952
2.

Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.

Gray DM, Zar H, Cotton M.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006418. doi: 10.1002/14651858.CD006418.pub2. Review.

3.
4.

Use of isoniazid preventive therapy for tuberculosis prophylaxis among people living with HIV/AIDS: a review of the literature.

Briggs MA, Emerson C, Modi S, Taylor NK, Date A.

J Acquir Immune Defic Syndr. 2015 Apr 15;68 Suppl 3:S297-305. doi: 10.1097/QAI.0000000000000497. Review.

PMID:
25768869
5.

Treatment of latent tuberculosis infection in HIV infected persons.

Akolo C, Adetifa I, Shepperd S, Volmink J.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD000171. doi: 10.1002/14651858.CD000171.pub3. Review.

PMID:
20091503
6.

Epidemiology of tuberculosis and HIV: recent advances in understanding and responses.

Martinson NA, Hoffmann CJ, Chaisson RE.

Proc Am Thorac Soc. 2011 Jun;8(3):288-93. doi: 10.1513/pats.201010-064WR. Review.

7.

Tuberculosis preventive therapy: an underutilised strategy to reduce individual risk of TB and contribute to TB control.

Churchyard GJ, Chaisson RE, Maartens G, Getahun H.

S Afr Med J. 2014 Apr 16;104(5):339-43. doi: 10.7196/samj.8290. Review.

PMID:
25212199
8.

HIV infection and multidrug-resistant tuberculosis: the perfect storm.

Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A, Castro KG, Weyer K.

J Infect Dis. 2007 Aug 15;196 Suppl 1:S86-107. Review.

9.

New vaccines for the prevention of tuberculosis in human immunodeficiency virus infection.

von Reyn CF, Bakari M, Arbeit RD, Lahey T, Ramadhani A, Egwaga S.

Int J Tuberc Lung Dis. 2012 Jun;16(6):718-23. doi: 10.5588/ijtld.11.0444. Epub 2012 Apr 9. Review.

PMID:
22507085
10.

Isoniazid preventive therapy in HIV-infected and -uninfected children (0 - 14 years).

Schaaf HS, Cotton MF, Boon GP, Jeena PM.

S Afr Med J. 2013 Sep 4;103(10):714-5. doi: 10.7196/samj.7189. Review.

PMID:
24079619
11.
12.

Intensive case finding and isoniazid preventative therapy in HIV infected individuals in Africa: economic model and value of information analysis.

Maheswaran H, Barton P.

PLoS One. 2012;7(1):e30457. doi: 10.1371/journal.pone.0030457. Epub 2012 Jan 23. Review.

13.

Isoniazid preventive therapy in correctional facilities: a systematic review.

Al-Darraji HA, Kamarulzaman A, Altice FL.

Int J Tuberc Lung Dis. 2012 Jul;16(7):871-9. doi: 10.5588/ijtld.11.0447. Epub 2012 Mar 7. Review.

PMID:
22410101
14.

Preventive therapy for tuberculosis in HIV infected individuals.

Padmapriyadarsini C, Swaminathan S.

Indian J Med Res. 2005 Apr;121(4):415-23. Review.

PMID:
15817954
15.

Systematic review of TST responses in people living with HIV in under-resourced settings: implications for isoniazid preventive therapy.

Kerkhoff AD, Kranzer K, Samandari T, Nakiyingi-Miiro J, Whalen CC, Harries AD, Lawn SD.

PLoS One. 2012;7(11):e49928. doi: 10.1371/journal.pone.0049928. Epub 2012 Nov 27. Review. Erratum in: PLoS One. 2013;8(5). doi: 10.1371/annotation/e4800fcf-c58a-4d5a-a90a-bb6aed93454a.

16.

Tuberculosis and HIV co-infection in children.

Venturini E, Turkova A, Chiappini E, Galli L, de Martino M, Thorne C.

BMC Infect Dis. 2014;14 Suppl 1:S5. doi: 10.1186/1471-2334-14-S1-S5. Epub 2014 Jan 8. Review.

17.

Review of policy and status of implementation of collaborative HIV-TB activities in 23 high-burden countries.

Gupta S, Granich R, Date A, Lepere P, Hersh B, Gouws E, Samb B.

Int J Tuberc Lung Dis. 2014 Oct;18(10):1149-58. doi: 10.5588/ijtld.13.0889. Review.

PMID:
25216827
18.

HIV and tuberculosis--science and implementation to turn the tide and reduce deaths.

Harries AD, Lawn SD, Getahun H, Zachariah R, Havlir DV.

J Int AIDS Soc. 2012;15(2):17396. Review.

19.

Debunking the myths perpetuating low implementation of isoniazid preventive therapy amongst human immunodeficiency virus-infected persons.

Akolo C, Bada F, Okpokoro E, Nwanne O, Iziduh S, Usoroh E, Ali T, Ibeziako V, Oladimeji O, Odo M.

World J Virol. 2015 May 12;4(2):105-12. doi: 10.5501/wjv.v4.i2.105. Review.

20.

Interventions to improve delivery of isoniazid preventive therapy: an overview of systematic reviews.

Adams LV, Talbot EA, Odato K, Blunt H, Steingart KR.

BMC Infect Dis. 2014 May 21;14:281. doi: 10.1186/1471-2334-14-281. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk